The comparison assessment of effectiveness of low-dose aspirin in women with gestational endotheliopathy for prevention of preeclampsia depending on beginning of treatment

Abstract

We are estimated the effect of low-dose aspirin (75 mg/day) depending on beginning (gestational age 11-14 vs. 16-20 weeks) in women with gestational endotheliopathy, on the incidence of preeclampsia and other perinatal complications. Our investigation showed statistically significant effect of low-dose aspirin initiated in 11-14 weeks in preventing the incidence of preeclampsia and IUGR in women with gestational endotheliopathy.